Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells

Biochemical and Biophysical Research Communications

Volumn 380, Issue 2, 2009, Pages 313-317

  Lee, Ha Young ^a   Kim, Sang Doo ^a   Shim, Jae Woong ^a   Yun, Jeanho ^a   Kim, Koanhoi ^b   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Atherosclerosis; C C chemokine motif ligand 2; Endothelial cells; Formyl peptide receptor like 1; Serum amyloid A

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; SMALL INTERFERING RNA;

ARTICLE; ATHEROSCLEROSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; HUMANS; RECEPTORS, FORMYL PEPTIDE; SERUM AMYLOID A PROTEIN; UMBILICAL VEINS;

EID: 60349088355     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.068     Document Type: Article

References (31)

1. Li A.C., and Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8 (2002) 1235-1242
2. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., and Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92 (1995) 8264-8268
3. Valente A.J., Graves D.T., Vialle-Valentin C.E., Delgado R., and Schwartz C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27 (1988) 4162-4268
4. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., Rollins B.J., and Charo I.F. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103 (1999) 773-778
5. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
6. Inoue S., Egashira K., Ni W., Kitamoto S., Usui M., Otani K., Ishibashi M., Hiasa K., Nishida K., and Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106 (2002) 2700-2706
7. Crimi E., Ignarro L.J., and Napoli C. Microcirculation and oxidative stress. Free Radic. Res. 41 (2007) 1364-1375
8. Davenpeck K.L., Zagorski J., Schleimer R.P., and Bochner B.S. Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J. Immunol. 161 (1998) 6861-6870
9. Shin W.S., Szuba A., and Rockson S.G. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 160 (2002) 91-102
10. Rollins B.J., Yoshimura T., Leonard E.J., and Pober J.S. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136 (1990) 1229-1233
11. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265 (1999) 501-523
12. Urieli-Shoval S., Linke R.P., and Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7 (2000) 64-69
13. Malle E., Steinmetz A., and Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102 (1993) 131-146
14. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., Kelvin D.J., and Oppenheim J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180 (1994) 203-209
15. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., and Wang J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189 (1999) 395-402
16. Kang H.K., Lee H.Y., Kim M.K., Park K.S., Park Y.M., Kwak J.Y., and Bae Y.S. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175 (2005) 685-692
17. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
18. Jo E.J., Lee H.Y., Lee Y.N., Kim J.I., Kang H.K., Park D.W., Baek S.H., Kwak J.Y., and Bae Y.S. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J. Immunol. 173 (2004) 6433-6439
19. Lee M.S., Yoo S.A., Cho C.S., Suh P.G., Kim W.U., and Ryu S.H. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 177 (2006) 5585-5594
20. Esteban V., Ruperez M., Sanchez-Lopez E., Rodriguez-Vita J., Lorenzo O., Demaegdt H., Vanderheyden P., Egido J., and Ruiz-Ortega M. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ. Res. 96 (2005) 965-973
21. Yamada M., Kim S., Egashira K., Takeya M., Ikeda T., Mimura O., and Iwao H. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1996-2001
22. O'Brien K.D., and Chait A. Serum amyloid A: the "other" inflammatory protein. Curr. Atheroscler. Rep. 8 (2006) 62-68
23. Fyfe A.I., Rothenberg L.S., DeBeer F.C., Cantor R.M., Rotter J.I., and Lusis A.J. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96 (1997) 2914-2919
24. O'Brien K.D., McDonald T.O., Kunjathoor V., Eng K., Knopp E.A., Lewis K., Lopez R., Kirk E.A., Chait A., Wight T.N., deBeer F.C., and LeBoeuf R.C. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 785-790
25. Malle E., and De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26 (1996) 427-435
26. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., and Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6 (2000) 643-651
27. Cai L., de Beer M.C., de Beer F.C., and van der Westhuyzen D.R. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 280 (2005) 2954-2961
28. Baranova I.N., Vishnyakova T.G., Bocharov A.V., Kurlander R., Chen Z., Kimelman M.L., Remaley A.T., Csako G., Thomas F., Eggerman T.L., and Patterson A.P. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280 (2005) 8031-8040
29. Christenson K., Björkman L., Tängemo C., and Bylund J. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukoc. Biol. 83 (2008) 139-148
30. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., and Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J. Leukoc. Biol. 83 (2008) 1174-1180
31. Lee H.Y., Kim S.D., Shim J.W., Lee S.Y., Lee H., Cho K.H., Yun J., and Bae Y.S. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J. Immunol. 181 (2008) 4332-4339